Showing results (11-20 of 221) with videos related to
Sort By:
Pageof 23
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 11, 2020
NKp46+ lamina propria natural killer cells undergo metabolic reprogramming in a mouse experimental colitis modelHongjian Zhou, Xingwang Xie, Bin Jiang, et al.Immunological Investigations|December 5, 2023
The Mechanistic Target of Rapamycin Complex 1 Pathway Contributes to the Anti-Tumor Effect of Granulocyte-Macrophage-Colony-Stimulating Factor-Producing T Helper Cells in Mouse Colorectal CancerHongjian Zhou, Bin Jiang, Yuyuan Qian, et al.Frontiers in Pharmacology|September 6, 2023
Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and futureXiao-Er Tang, Ya-Qiong Cheng, Chao-Ke TangClinica Chimica Acta; International Journal of Clinical Chemistry|June 17, 2015
The protective functions of omentin in cardiovascular diseasesYu-Lin Tan, Xi-Long Zheng, Chao-Ke TangAdvances in Clinical Chemistry|September 29, 2015
Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke TangAtherosclerosis|February 7, 2012
Psychological stress, immune response, and atherosclerosisHong-feng Gu, Chao-ke Tang, Yong-zong YangAdvances in Clinical Chemistry|August 2, 2015
Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke TangSheng Li Ke Xue Jin Zhan [Progress in Physiology]|May 31, 2014
[Lipoprotein lipase and diabetic cardiomyopathy]Xiang-Yu Liu, Wei-Dong Yin, Chao-Ke TangClinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 2019
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic targetJia-Hui Gao, Xiao-Hua Yu, Chao-Ke TangCytokine|February 22, 2023
CTRP1: A novel player in cardiovascular and metabolic diseasesYang Wang, Heng Li, Xiao-Hua Yu, et al.Pageof 23